<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">52330</article-id><article-id pub-id-type="doi">10.7554/eLife.52330</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-161570"><name><surname>Kumar</surname><given-names>Alok</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-161572"><name><surname>Chamoto</surname><given-names>Kenji</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-161571"><name><surname>Chowdhury</surname><given-names>Partha S</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-135325"><name><surname>Honjo</surname><given-names>Tasuku</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2300-3928</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Immunology and Genomic Medicine</institution>, <institution>Kyoto University</institution>, <addr-line><named-content content-type="city">Kyoto</named-content></addr-line>, <country>Japan</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-122807"><name><surname>Kawakami</surname><given-names>Yutaka</given-names></name><role>Reviewing editor</role><aff><institution>Keio University School of Medicine</institution>, <country>Japan</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>honjo@mfour.med.kyoto-u.ac.jp</email> (TH);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>03</day><month>03</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e52330</elocation-id><history><date date-type="received"><day>01</day><month>10</month><year>2019</year></date><date date-type="accepted"><day>11</day><month>02</month><year>2020</year></date></history><permissions><copyright-statement>Â© 2020, Kumar et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Kumar et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-52330-v1.pdf"/><abstract><p>PD-1 blockade therapy has revolutionized cancer treatments. However, a substantial population of patients is unresponsive. To rescue unresponsive patients, the mechanism of unresponsiveness to PD-1 blockade therapy must be elucidated. Using a 'bilateral tumor model' where responsive and unresponsive tumors were inoculated into different sides of the mouse belly, we demonstrated that unresponsive tumors can be categorized into two groups: with and without systemic immunosuppressive property (SIP). The SIP-positive tumors released uncharacterized, non-proteinaceous small molecules that inhibited T cell proliferation and mitochondrial activation. By contrast, the SIP-negative B16 tumor escaped from immunity by losing MHC class I expression. Unresponsiveness of SIP-positive tumors was partially overcome by improving the mitochondrial function with a mitochondrial activator; this was not successful for B16, which employs immune ignorance. These results demonstrated that 'bilateral tumor model' was useful for stratifying tumors to investigate the mechanism of unresponsiveness and develop a strategy for proper combination therapy.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009619</institution-id><institution>Japan Agency for Medical Research and Development</institution></institution-wrap></funding-source><award-id>JP19cm0106302</award-id><principal-award-recipient><name><surname>Honjo</surname><given-names>Tasuku</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009619</institution-id><institution>Japan Agency for Medical Research and Development</institution></institution-wrap></funding-source><award-id>JP19gm0710012</award-id><principal-award-recipient><name><surname>Honjo</surname><given-names>Tasuku</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: His study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee of Kyoto University. The protocol was approved by the Committee on the Ethics of Animal Experiments of the Kyoto University (Permit Number: Medkyo19080). All surgery was performed under sodium pentobarbital anesthesia, and every effort was made to minimize suffering.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>We have uploaded qPCR primers sequences related to Supplementary Figure S6 to 'Dryad repositories'. doi:10.5061/dryad.vq83bk3np</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Kumar A</collab><collab>Chamoto K</collab><collab>Chowdhury PS</collab><collab>Honjo T</collab></person-group><year iso-8601-date="2019">2019</year><source>Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy</source><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5061/dryad.vq83bk3np">http://dx.doi.org/10.5061/dryad.vq83bk3np</ext-link><comment>Dryad Digital Repository, doi:10.5061/dryad.vq83bk3np</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-52330-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>